The survey performed in collaboration between NBTC National Transfusion Laboratory Managers Group and NHSBT investigated the final fate of 5,653 O D Negative red cells issued to hospitals over a two-week period in September 2024. Please review the main report with your HTT, HTC and RTC groups.
Audits and Surveys for South East
Proposals are to be agreed by your Regional Transfusion Committee (RTC) and your Patient Blood Management Practioner, then email the audit manager (brian.hockley@nhsbt.nhs.uk) to progress.
Proposals can be submitted online at: RTC Clinical Audit-Survey Proposals Submission Form
Current activity
Survey on the Use of Group O D Negative Red Cells
The survey performed in collaboration between NBTC National Transfusion Laboratory Managers Group and NHSBT investigated the final fate of 5,653 O D Negative red cells issued to hospitals over a two-week period in September 2024. Please review the main report with your HTT, HTC and RTC groups.
| Attachment | Size |
|---|---|
| O Neg Survey Report | 966.13 KB |
Review of Direct Oral Anti-Coagulants (DOACs) and Warfarin Reversal in Trauma Patients
Just prior to the start of the COVID-19 pandemic in 2020, this group was mandated by the London Major Trauma Steering Group with the task of
1) identifying if all trauma units (TU) had reversal guidelines for anticoagulation, particularly for the DOACs.
2) to assess if the guidance’s were being followed.
The report outlines the findings of the original survey, pilot study and the results of the audit undertaken between January-March 2022.
Review of Direct Oral Anti-Coagulants (DOACs) and Warfarin Reversal in Trauma Patients
Just prior to the start of the COVID-19 pandemic in 2020, this group was mandated by the London Major Trauma Steering Group with the task of
1) identifying if all trauma units (TU) had reversal guidelines for anticoagulation, particularly for the DOACs.
2) to assess if the guidance’s were being followed.
The report outlines the findings of the original survey, pilot study and the results of the audit undertaken between January-March 2022.